Open Insider Trading Activity for Bridgebio Pharma, Inc. Chief Executive Officer Kumar Neil
31-day price and insider activity (up to 2 years)
Daily candles with triangles for the buy and sale transactions shown below. Scroll left or zoom out to load earlier candles (up to 2 years).
▲ Insider buy
▼ Insider sale
Loading daily price history…
Charting by TradingView Lightweight Charts
| Ticker | Filing Date | Transaction Date | Company | Insider | Title | Transaction | Trade Count | Shares | Avg. Price | Total Value | Position Size Change | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10b5-1: Scheduled Form 4 Transaction BBIO | 2026-05-26 | 2026-05-21 | Bridgebio Pharma, Inc. | Kumar Neil | Chief Executive Officer | Sell | 5 | 26,103 | $69.44 | $1,812,475.26 | 2.01% | View Filing |
| 10b5-1: Scheduled Form 4 Transaction BBIO | 2026-05-11 | 2026-05-08 | Bridgebio Pharma, Inc. | Kumar Neil | Chief Executive Officer | Sell | 12 | 80,000 | $67.40 | $5,392,321.30 | 0.27% | View Filing |